A new trading day began on Monday, with Fractyl Health Inc (NASDAQ: GUTS) stock price down -4.46% from the previous day of trading, before settling in for the closing price of $1.12. GUTS’s price has ranged from $1.07 to $7.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -4.50%. Meanwhile, its annual earnings per share averaged 12.35%. With a float of $20.86 million, this company’s outstanding shares have now reached $48.76 million.
The extent of productivity of a business whose workforce counts for 107 workers is very important to gauge. In terms of profitability, gross margin is -10.75%, operating margin of -100570.97%, and the pretax margin is -73864.52%.
Fractyl Health Inc (GUTS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Fractyl Health Inc is 57.37%, while institutional ownership is 34.80%. The most recent insider transaction that took place on Mar 14 ’25, was worth 22,980. In this transaction Director of this company bought 17,901 shares at a rate of $1.28, taking the stock ownership to the 17,901 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 31,000 for $1.30, making the entire transaction worth $40,210. This insider now owns 31,000 shares in total.
Fractyl Health Inc (GUTS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.72% during the next five years compared to -12.32% drop over the previous five years of trading.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Here are Fractyl Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 581.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.71 in one year’s time.
Technical Analysis of Fractyl Health Inc (GUTS)
The latest stats from [Fractyl Health Inc, GUTS] show that its last 5-days average volume of 0.34 million was superior to 0.3 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 18.80%. Additionally, its Average True Range was 0.11.
During the past 100 days, Fractyl Health Inc’s (GUTS) raw stochastic average was set at 3.55%, which indicates a significant decrease from 18.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.22% in the past 14 days, which was lower than the 81.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4437, while its 200-day Moving Average is $2.4560. Now, the first resistance to watch is $1.1567. This is followed by the second major resistance level at $1.2433. The third major resistance level sits at $1.3167. If the price goes on to break the first support level at $0.9967, it is likely to go to the next support level at $0.9233. The third support level lies at $0.8367 if the price breaches the second support level.
Fractyl Health Inc (NASDAQ: GUTS) Key Stats
With a market capitalization of 52.34 million, the company has a total of 48,920K Shares Outstanding. Currently, annual sales are 90 K while annual income is -68,690 K. The company’s previous quarter sales were 10 K while its latest quarter income was -23,170 K.
